MedTrace Logo

Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience

NCT05950737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2024-10-30

No results posted yet for this study

Summary

Sentinel node biopsy is a suitable alternative to END and is recommended in standard guidelines. Investigators have been doing SNB in their department to standardize the process for the last two years. This study aims to analyze the diagnostic accuracy of the SNB performed to standardize the procedure at their institute.

Conditions

  • Oral Cavity Squamous Cell Carcinoma

Interventions

PROCEDURE

Sentinel node biopsy

All patients have undergone completion neck dissection following SNB in the process of standardization.

Sponsors & Collaborators

  • Tata Memorial Hospital

    lead OTHER_GOV

Principal Investigators

  • Richa Vaish, MS. M.Ch · Tata Memorial Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950737 on ClinicalTrials.gov